Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
“Vitamin D therapy market to register a CAGR of 11.6% from 2019 to 2024.”
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency, growing focus on healthy diets among consumers, and the presence of a large target patient population. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. On the other hand, the fortification of foods is likely to challenge market growth to a certain extent.
“Oral route of administration accounted for a significant share of the market, by route of administration, in 2018.”
By route of administration, the vitamin D therapy market is segmented into oral and parenteral routes of administration. In 2018, the oral route of administration accounted for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. This is mainly due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, and a higher preference for the oral route.
“By purchasing pattern, prescription drugs held the largest share of the vitamin D therapy market in 2018.”
On the basis of purchasing pattern, the vitamin D therapy market is segmented into OTC and prescription drugs. In 2018, the prescription drugs segment accounted for the largest share of the vitamin D therapy market. The large share of this segment can be attributed to the fact that vitamin D deficiency is mostly diagnosed by registered medical practitioners that provide prescriptions for appropriate medications.
“Asia Pacific dominated the vitamin D therapy market in 2018.”
The Asia Pacific, which includes China, Japan, India, and the Rest of Asia Pacific, accounted for the largest share of the vitamin D therapy market. The large share of this market segment can be attributed to the increasing awareness about vitamin D deficiency and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, atypical diets, decreasing sun exposure, and rising malnutrition levels.
Breakdown of supply-side primary interviews, by company type, designation, and region:
This report studies the vitamin D therapy market by route of administration, application, age group, purchasing pattern, and region. The report also analyzes factors such as drivers, opportunities, and challenges affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vitamin D therapy market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency, growing focus on healthy diets among consumers, and the presence of a large target patient population. Emerging economies with growing healthcare expenditures are also expected to provide opportunities for the growth of the market. On the other hand, the fortification of foods is likely to challenge market growth to a certain extent.
“Oral route of administration accounted for a significant share of the market, by route of administration, in 2018.”
By route of administration, the vitamin D therapy market is segmented into oral and parenteral routes of administration. In 2018, the oral route of administration accounted for the largest market share. This segment is also expected to grow at the highest CAGR during the forecast period. This is mainly due to the ease of administration, better pharmacokinetic and pharmacodynamic activity, and a higher preference for the oral route.
“By purchasing pattern, prescription drugs held the largest share of the vitamin D therapy market in 2018.”
On the basis of purchasing pattern, the vitamin D therapy market is segmented into OTC and prescription drugs. In 2018, the prescription drugs segment accounted for the largest share of the vitamin D therapy market. The large share of this segment can be attributed to the fact that vitamin D deficiency is mostly diagnosed by registered medical practitioners that provide prescriptions for appropriate medications.
“Asia Pacific dominated the vitamin D therapy market in 2018.”
The Asia Pacific, which includes China, Japan, India, and the Rest of Asia Pacific, accounted for the largest share of the vitamin D therapy market. The large share of this market segment can be attributed to the increasing awareness about vitamin D deficiency and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, heavy air pollution, sedentary lifestyles, increasing incidence of vitamin D deficiency, atypical diets, decreasing sun exposure, and rising malnutrition levels.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 - 20%, Tier 2 - 45%, and Tier 3 - 35%
- By Designation: C-level - 30%, Director-level - 20%, and Others - 50%
- By Region: North America - 35%, Europe - 24%, Asia Pacific - 25%, and RoW - 16%
This report studies the vitamin D therapy market by route of administration, application, age group, purchasing pattern, and region. The report also analyzes factors such as drivers, opportunities, and challenges affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total vitamin D therapy market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on vitamin D offered by the top 10 players in the vitamin D therapy market. The report analyzes the market by route of administration, application, age group, purchasing pattern, and region
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various vitamin D supplements across key geographic regions
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vitamin D therapy market
- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the vitamin D therapy market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VITAMIN D: MARKET OVERVIEW
4.2 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION (2019)
4.3 GEOGRAPHICAL SNAPSHOT OF THE VITAMIN D THERAPY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing awareness about vitamin d deficiency among consumers
5.2.1.2 Presence of a large target patient population
5.2.2 MARKET OPPORTUNITIES
5.2.2.1 Growth opportunities in countries with a high prevalence of undernutrition
5.2.3 MARKET CHALLENGES
5.2.3.1 Fortified foods
6 ROLE OF VITAMIN D IN DISEASE PROGRESSION
6.1 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CANCER
6.2 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF DIABETES
6.3 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
7 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION
7.1 INTRODUCTION
7.2 ORAL ROUTE OF ADMINISTRATION
7.2.1 ORAL ROUTE OF ADMINISTRATION LIKELY TO DOMINATE THE VITAMIN D THERAPY MARKET DUE TO HIGH PATIENT COMPLIANCE
7.3 PARENTERAL ROUTE OF ADMINISTRATION
7.3.1 USE OF PARENTERALS IS MOSTLY RESERVED FOR HYPOVITAMINOSIS D
8 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN
8.1 INTRODUCTION
8.2 PRESCRIPTION DRUGS
8.2.1 GROWING HYPOVITAMINOSIS D PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET
8.3 OVER-THE-COUNTER DRUGS
8.3.1 EASE OF PURCHASE LEADS TO PEOPLE OPTING FOR OTC
9 VITAMIN D THERAPY MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 OSTEOPOROSIS
9.2.1 FRACTURES AND BROKEN BONES LEADING TO RISE IN VITAMIN D THERAPY MARKET
9.3 RICKETS
9.3.1 UPDATED GUIDELINES ON DAILY DIETARY INTAKE OF VITAMIN D LIKELY TO LOWER INCIDENCE OF RICKETS
9.4 MUSCLE WEAKNESS
9.4.1 EVIDENCE INDICATES IMPACT OF VITAMIN D ON ATHLETE AND INJURY PROFILES
9.5 AUTOIMMUNE DISORDERS
9.5.1 RESEARCH IS REQUIRED TO UNDERSTAND THE ROLE OF VITAMIN D IN AUTOIMMUNE DISORDERS
9.6 SKIN DISEASES
9.6.1 IMMUNOMODULATORY ACTIVITY OF VITAMIN D LIKELY TO INCREASE THE MARKET FOR PSORIASIS
9.7 OTHER APPLICATIONS
10 VITAMIN D THERAPY MARKET, BY AGE GROUP
10.1 INTRODUCTION
10.2 SENIOR ADULTS
10.2.1 INCREASING INCIDENCE OF OSTEOPOROSIS AMONG SENIOR ADULTS HAS DRIVEN DEMAND FOR VITAMIN D
10.3 ADULTS
10.3.1 SEDENTARY LIFESTYLES ARE LEADING TO HYPOVITAMINOSIS D AMONG ADULTS
10.4 CHILDREN
10.4.1 HIGH PREVALENCE OF RICKETS AMONG CHILDREN IS DRIVING MARKET GROWTH
11 VITAMIN D THERAPY MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate the North American vitamin D therapy market
11.2.2 CANADA
11.2.2.1 Limited endogenous synthesis and limited dietary sources are the major factors responsible for vitamin D deficiency in the Canadian population
11.3 EUROPE
11.3.1 UK
11.3.1.1 Vitamin D deficiency is prevalent among all age groups in the UK
11.3.2 GERMANY
11.3.2.1 High prevalence of osteoporosis is expected to be the key factor driving market growth in Germany
11.3.3 FRANCE
11.3.3.1 Vitamin D levels are declining in France
11.3.4 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Heavy air pollution and sedentary lifestyles are driving market growth in China
11.4.2 JAPAN
11.4.2.1 Increasing incidence of vitamin D deficiency in Japan to drive market growth
11.4.3 INDIA
11.4.3.1 A large part of India’s population is vitamin D-deficient
11.4.4 REST OF ASIA PACIFIC
11.5 REST OF THE WORLD
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET RANKING ANALYSIS, 2018
12.3 KEY STRATEGIES
12.3.1 ACQUISITIONS AND COLLABORATIONS, 2015–2018
12.4 COMPETITIVE LEADERSHIP MAPPING (2018)
12.4.1 VISIONARY LEADERS
12.4.2 INNOVATORS
12.4.3 DYNAMIC DIFFERENTIATORS
12.4.4 EMERGING COMPANIES
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 NOVARTIS AG
13.2 PFIZER INC
13.3 GLAXOSMITHKLINE PLC
13.4 MERCK & CO., INC.
13.5 ABBOTT
13.6 SANOFI
13.7 TORRENT PHARMACEUTICALS LTD.
13.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
13.9 ALKEM LABORATORIES LTD.
13.10 CADILA HEALTHCARE LTD.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 MARKETS COVERED
1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 SECONDARY DATA
2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2 PRIMARY DATA
2.2.1 KEY DATA FROM PRIMARY SOURCES
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 VITAMIN D: MARKET OVERVIEW
4.2 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION (2019)
4.3 GEOGRAPHICAL SNAPSHOT OF THE VITAMIN D THERAPY MARKET
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing awareness about vitamin d deficiency among consumers
5.2.1.2 Presence of a large target patient population
5.2.2 MARKET OPPORTUNITIES
5.2.2.1 Growth opportunities in countries with a high prevalence of undernutrition
5.2.3 MARKET CHALLENGES
5.2.3.1 Fortified foods
6 ROLE OF VITAMIN D IN DISEASE PROGRESSION
6.1 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CANCER
6.2 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF DIABETES
6.3 ROLE OF VITAMIN D IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
7 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION
7.1 INTRODUCTION
7.2 ORAL ROUTE OF ADMINISTRATION
7.2.1 ORAL ROUTE OF ADMINISTRATION LIKELY TO DOMINATE THE VITAMIN D THERAPY MARKET DUE TO HIGH PATIENT COMPLIANCE
7.3 PARENTERAL ROUTE OF ADMINISTRATION
7.3.1 USE OF PARENTERALS IS MOSTLY RESERVED FOR HYPOVITAMINOSIS D
8 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN
8.1 INTRODUCTION
8.2 PRESCRIPTION DRUGS
8.2.1 GROWING HYPOVITAMINOSIS D PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET
8.3 OVER-THE-COUNTER DRUGS
8.3.1 EASE OF PURCHASE LEADS TO PEOPLE OPTING FOR OTC
9 VITAMIN D THERAPY MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 OSTEOPOROSIS
9.2.1 FRACTURES AND BROKEN BONES LEADING TO RISE IN VITAMIN D THERAPY MARKET
9.3 RICKETS
9.3.1 UPDATED GUIDELINES ON DAILY DIETARY INTAKE OF VITAMIN D LIKELY TO LOWER INCIDENCE OF RICKETS
9.4 MUSCLE WEAKNESS
9.4.1 EVIDENCE INDICATES IMPACT OF VITAMIN D ON ATHLETE AND INJURY PROFILES
9.5 AUTOIMMUNE DISORDERS
9.5.1 RESEARCH IS REQUIRED TO UNDERSTAND THE ROLE OF VITAMIN D IN AUTOIMMUNE DISORDERS
9.6 SKIN DISEASES
9.6.1 IMMUNOMODULATORY ACTIVITY OF VITAMIN D LIKELY TO INCREASE THE MARKET FOR PSORIASIS
9.7 OTHER APPLICATIONS
10 VITAMIN D THERAPY MARKET, BY AGE GROUP
10.1 INTRODUCTION
10.2 SENIOR ADULTS
10.2.1 INCREASING INCIDENCE OF OSTEOPOROSIS AMONG SENIOR ADULTS HAS DRIVEN DEMAND FOR VITAMIN D
10.3 ADULTS
10.3.1 SEDENTARY LIFESTYLES ARE LEADING TO HYPOVITAMINOSIS D AMONG ADULTS
10.4 CHILDREN
10.4.1 HIGH PREVALENCE OF RICKETS AMONG CHILDREN IS DRIVING MARKET GROWTH
11 VITAMIN D THERAPY MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate the North American vitamin D therapy market
11.2.2 CANADA
11.2.2.1 Limited endogenous synthesis and limited dietary sources are the major factors responsible for vitamin D deficiency in the Canadian population
11.3 EUROPE
11.3.1 UK
11.3.1.1 Vitamin D deficiency is prevalent among all age groups in the UK
11.3.2 GERMANY
11.3.2.1 High prevalence of osteoporosis is expected to be the key factor driving market growth in Germany
11.3.3 FRANCE
11.3.3.1 Vitamin D levels are declining in France
11.3.4 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Heavy air pollution and sedentary lifestyles are driving market growth in China
11.4.2 JAPAN
11.4.2.1 Increasing incidence of vitamin D deficiency in Japan to drive market growth
11.4.3 INDIA
11.4.3.1 A large part of India’s population is vitamin D-deficient
11.4.4 REST OF ASIA PACIFIC
11.5 REST OF THE WORLD
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 MARKET RANKING ANALYSIS, 2018
12.3 KEY STRATEGIES
12.3.1 ACQUISITIONS AND COLLABORATIONS, 2015–2018
12.4 COMPETITIVE LEADERSHIP MAPPING (2018)
12.4.1 VISIONARY LEADERS
12.4.2 INNOVATORS
12.4.3 DYNAMIC DIFFERENTIATORS
12.4.4 EMERGING COMPANIES
13 COMPANY PROFILES
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 NOVARTIS AG
13.2 PFIZER INC
13.3 GLAXOSMITHKLINE PLC
13.4 MERCK & CO., INC.
13.5 ABBOTT
13.6 SANOFI
13.7 TORRENT PHARMACEUTICALS LTD.
13.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
13.9 ALKEM LABORATORIES LTD.
13.10 CADILA HEALTHCARE LTD.
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 2 VITAMIN D THERAPY MARKET FOR ORAL ROUTE OF ADMINISTRATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 3 VITAMIN D THERAPY MARKET FOR PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 4 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 5 VITAMIN D THERAPY MARKET FOR PRESCRIPTION DRUGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 VITAMIN D THERAPY MARKET FOR OTC DRUGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 8 VITAMIN D THERAPY MARKET FOR OSTEOPOROSIS, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 VITAMIN D THERAPY MARKET FOR RICKETS, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 VITAMIN D THERAPY MARKET FOR MUSCLE WEAKNESS, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 VITAMIN D THERAPY MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 VITAMIN D THERAPY MARKET FOR SKIN DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 VITAMIN D THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 15 VITAMIN D THERAPY MARKET FOR SENIOR ADULTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 VITAMIN D THERAPY MARKET FOR ADULTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 VITAMIN D THERAPY MARKET FOR CHILDREN, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 VITAMIN D THERAPY MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 21 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 22 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 24 US: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 25 US: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 26 US: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27 US: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 28 CANADA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 29 CANADA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 30 CANADA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 31 CANADA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 32 EUROPE: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 EUROPE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 35 EUROPE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 EUROPE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 37 UK: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 38 UK: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 39 UK: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 40 UK: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 41 GERMANY: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 42 GERMANY: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 43 GERMANY: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 44 GERMANY: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 45 FRANCE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 46 FRANCE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 47 FRANCE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 49 ROE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 50 ROE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 51 ROE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 52 ROE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 53 APAC: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 54 APAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 55 APAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 56 APAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 APAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 58 CHINA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 59 CHINA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 60 CHINA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 61 CHINA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 62 JAPAN: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 63 JAPAN: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 64 JAPAN: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 65 JAPAN: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 66 INDIA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 67 INDIA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 68 INDIA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 69 INDIA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 70 ROAPAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 71 ROAPAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 72 ROAPAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 73 ROAPAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 74 ROW: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 75 ROW: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 76 ROW: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 77 ROW: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 1 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 2 VITAMIN D THERAPY MARKET FOR ORAL ROUTE OF ADMINISTRATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 3 VITAMIN D THERAPY MARKET FOR PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2017–2024 (USD MILLION)
TABLE 4 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 5 VITAMIN D THERAPY MARKET FOR PRESCRIPTION DRUGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 6 VITAMIN D THERAPY MARKET FOR OTC DRUGS, BY REGION, 2017–2024 (USD MILLION)
TABLE 7 VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 8 VITAMIN D THERAPY MARKET FOR OSTEOPOROSIS, BY REGION, 2017–2024 (USD MILLION)
TABLE 9 VITAMIN D THERAPY MARKET FOR RICKETS, BY REGION, 2017–2024 (USD MILLION)
TABLE 10 VITAMIN D THERAPY MARKET FOR MUSCLE WEAKNESS, BY REGION, 2017–2024 (USD MILLION)
TABLE 11 VITAMIN D THERAPY MARKET FOR AUTOIMMUNE DISORDERS, BY REGION, 2017–2024 (USD MILLION)
TABLE 12 VITAMIN D THERAPY MARKET FOR SKIN DISEASES, BY REGION, 2017–2024 (USD MILLION)
TABLE 13 VITAMIN D THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION)
TABLE 14 VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 15 VITAMIN D THERAPY MARKET FOR SENIOR ADULTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 16 VITAMIN D THERAPY MARKET FOR ADULTS, BY REGION, 2017–2024 (USD MILLION)
TABLE 17 VITAMIN D THERAPY MARKET FOR CHILDREN, BY REGION, 2017–2024 (USD MILLION)
TABLE 18 VITAMIN D THERAPY MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 21 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 22 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 24 US: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 25 US: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 26 US: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27 US: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 28 CANADA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 29 CANADA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 30 CANADA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 31 CANADA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 32 EUROPE: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 33 EUROPE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 34 EUROPE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 35 EUROPE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 EUROPE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 37 UK: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 38 UK: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 39 UK: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 40 UK: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 41 GERMANY: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 42 GERMANY: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 43 GERMANY: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 44 GERMANY: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 45 FRANCE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 46 FRANCE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 47 FRANCE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 48 FRANCE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 49 ROE: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 50 ROE: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 51 ROE: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 52 ROE: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 53 APAC: VITAMIN D THERAPY MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 54 APAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 55 APAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 56 APAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 APAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 58 CHINA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 59 CHINA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 60 CHINA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 61 CHINA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 62 JAPAN: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 63 JAPAN: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 64 JAPAN: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 65 JAPAN: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 66 INDIA: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 67 INDIA: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 68 INDIA: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 69 INDIA: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 70 ROAPAC: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 71 ROAPAC: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 72 ROAPAC: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 73 ROAPAC: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
TABLE 74 ROW: VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2017–2024 (USD MILLION)
TABLE 75 ROW: VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2017–2024 (USD MILLION)
TABLE 76 ROW: VITAMIN D THERAPY MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 77 ROW: VITAMIN D THERAPY MARKET, BY AGE GROUP, 2017–2024 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 VITAMIN D THERAPY MARKET: BOTTOM-UP APPROACH
FIGURE 4 VITAMIN D THERAPY MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2019 VS. 2024 (USD MILLION)
FIGURE 7 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2019 VS. 2024 (USD MILLION)
FIGURE 8 VITAMIN D THERAPY MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 9 VITAMIN D THERAPY MARKET, BY AGE GROUP, 2019 VS. 2024 (USD MILLION)
FIGURE 10 VITAMIN D THERAPY MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
FIGURE 11 GROWING AWARENESS ABOUT VITAMIN D DEFICIENCY AND LARGE PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 12 ORAL ROUTE OF ADMINISTRATION TO DOMINATE THE NORTH AMERICAN VITAMIN D THERAPY MARKET IN 2019
FIGURE 13 ASIAN COUNTRIES TO REGISTER HIGH GROWTH RATES DURING THE FORECAST PERIOD
FIGURE 14 VITAMIN D THERAPY MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NORTH AMERICA: VITAMIN D THERAPY MARKET SNAPSHOT
FIGURE 16 ASIA PACIFIC: VITAMIN D THERAPY MARKET SNAPSHOT
FIGURE 17 KEY DEVELOPMENTS IN THE VITAMIN D THERAPY MARKET FROM 2015 TO 2018
FIGURE 18 VITAMIN D THERAPY MARKET RANKING, BY KEY PLAYER, 2018
FIGURE 19 MNM DIVE-VENDOR COMPARISON MATRIX: VITAMIN D THERAPY MARKET
FIGURE 20 NOVARTIS AG: COMPANY SNAPSHOT (2018)
FIGURE 21 PFIZER INC.: COMPANY SNAPSHOT (2018)
FIGURE 22 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2018)
FIGURE 23 MERCK & CO., INC.: COMPANY SNAPSHOT (2018)
FIGURE 24 ABBOTT: COMPANY SNAPSHOT (2018)
FIGURE 25 SANOFI: COMPANY SNAPSHOT
FIGURE 26 TORRENT: COMPANY SNAPSHOT (2018)
FIGURE 27 SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2018)
FIGURE 28 ALKEM LABORATORIES LTD.: COMPANY SNAPSHOT (2018)
FIGURE 29 CADILA HEALTHCARE LTD.: COMPANY SNAPSHOT (2018)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 VITAMIN D THERAPY MARKET: BOTTOM-UP APPROACH
FIGURE 4 VITAMIN D THERAPY MARKET: TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 VITAMIN D THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2019 VS. 2024 (USD MILLION)
FIGURE 7 VITAMIN D THERAPY MARKET, BY PURCHASING PATTERN, 2019 VS. 2024 (USD MILLION)
FIGURE 8 VITAMIN D THERAPY MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 9 VITAMIN D THERAPY MARKET, BY AGE GROUP, 2019 VS. 2024 (USD MILLION)
FIGURE 10 VITAMIN D THERAPY MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
FIGURE 11 GROWING AWARENESS ABOUT VITAMIN D DEFICIENCY AND LARGE PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 12 ORAL ROUTE OF ADMINISTRATION TO DOMINATE THE NORTH AMERICAN VITAMIN D THERAPY MARKET IN 2019
FIGURE 13 ASIAN COUNTRIES TO REGISTER HIGH GROWTH RATES DURING THE FORECAST PERIOD
FIGURE 14 VITAMIN D THERAPY MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
FIGURE 15 NORTH AMERICA: VITAMIN D THERAPY MARKET SNAPSHOT
FIGURE 16 ASIA PACIFIC: VITAMIN D THERAPY MARKET SNAPSHOT
FIGURE 17 KEY DEVELOPMENTS IN THE VITAMIN D THERAPY MARKET FROM 2015 TO 2018
FIGURE 18 VITAMIN D THERAPY MARKET RANKING, BY KEY PLAYER, 2018
FIGURE 19 MNM DIVE-VENDOR COMPARISON MATRIX: VITAMIN D THERAPY MARKET
FIGURE 20 NOVARTIS AG: COMPANY SNAPSHOT (2018)
FIGURE 21 PFIZER INC.: COMPANY SNAPSHOT (2018)
FIGURE 22 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2018)
FIGURE 23 MERCK & CO., INC.: COMPANY SNAPSHOT (2018)
FIGURE 24 ABBOTT: COMPANY SNAPSHOT (2018)
FIGURE 25 SANOFI: COMPANY SNAPSHOT
FIGURE 26 TORRENT: COMPANY SNAPSHOT (2018)
FIGURE 27 SUN PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2018)
FIGURE 28 ALKEM LABORATORIES LTD.: COMPANY SNAPSHOT (2018)
FIGURE 29 CADILA HEALTHCARE LTD.: COMPANY SNAPSHOT (2018)
